<code id='7C586CB458'></code><style id='7C586CB458'></style>
    • <acronym id='7C586CB458'></acronym>
      <center id='7C586CB458'><center id='7C586CB458'><tfoot id='7C586CB458'></tfoot></center><abbr id='7C586CB458'><dir id='7C586CB458'><tfoot id='7C586CB458'></tfoot><noframes id='7C586CB458'>

    • <optgroup id='7C586CB458'><strike id='7C586CB458'><sup id='7C586CB458'></sup></strike><code id='7C586CB458'></code></optgroup>
        1. <b id='7C586CB458'><label id='7C586CB458'><select id='7C586CB458'><dt id='7C586CB458'><span id='7C586CB458'></span></dt></select></label></b><u id='7C586CB458'></u>
          <i id='7C586CB458'><strike id='7C586CB458'><tt id='7C586CB458'><pre id='7C586CB458'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:21839
          A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT
          Joe Buglewicz/Bloomberg

          Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

          A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

          advertisement

          The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Medical device trials still don't enroll enough women, study finds
          Medical device trials still don't enroll enough women, study finds

          AdobeWomenhavealwaysbeenunderrepresentedinmedicalresearch.Anewstudyrevealsthatnotmuchhaschanged,espe

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Readers discuss the intersection of pregnancy and addiction

          MollyFergusonforSTATFirstOpinionisSTAT’splatformforinteresting,illuminating,andmaybeevenprovocativea